Full Description
Cancer Immunotherapy, Volume 209 covers the progress that has been made in cancer immunotherapy. This volume surveys exciting developments in the field while also highlighting its promise and problems. Chapters in this release include The Promise, Progress, and Challenges of In Situ Immunization Agents in Cancer Immunotherapy, Breakthroughs in Synthetic Controlling Strategies for Precision in CAR-T Therapy, Non-coding RNAs in cancer immunotherapy: a solution to overcome immune resistance?, Rational Design of adjuvants boosts cancer vaccines, Emerging Drug delivery systems to alter Tumor immunosuppressive microenvironment: overcoming the challenges in immunotherapy for Glioblastoma.
Other chapters cover Magnetic Nanoparticles: An Emerging Nanomedicine for Cancer Immunotherapy and Clinical and basic science aspects of innate lymphoid cells as novel immunotherapeutic targets in cancer treatment.
Contents
1. The Promise, Progress, and Challenges of In Situ Immunization Agents in Cancer Immunotherapy
Matt Giacalone
2. TBA
Tiziana Vavalà
3. Breakthroughs in Synthetic Controlling Strategies for Precision in CAR-T Therapy
Rio Sugimura and Logan Tang
4. Non-coding RNAs in cancer immunotherapy: a solution to overcome immune resistance?
Moein Ala, Fatemeh Afra, Seyed Parsa Eftekhar and Amir Salehi Farid
5. Rational Design of adjuvants boosts cancer vaccines
Xia Li, Mitsuhiro Ebara, Naoto Shirahata, Tomohiko Yamazaki and Nobutaka Hanagata
6. Emerging Drug delivery systems to alter Tumor immunosuppressive microenvironment: overcoming the challenges in immunotherapy for Glioblastoma
Khushwant S. Yadav
7. MAGNETIC NANOPARTICLES: AN EMERGING NANOMEDICINE FOR CANCER IMMUNOTHERAPY
Phoomipat Jungcharoen, Jutatip Panaampon, Thanit Imemkamon and Charupong Saengboonmee
8. TBA
Mi Liu
9. TBA
Sarbajit Mukherjee
10. TBA
Gerardo Cazzato III
11. Clinical and basic science aspects of innate lymphoid cells as novel immunotherapeutic targets in cancer treatment
Eric Jou
